NCT04596046View on ClinicalTrials.gov

Could Intralesional Steroid be the Novel Treatment for Granulomatous Mastitis?

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

June 15, 2020

Study Completion Date

July 17, 2020

Conditions
Granulomatous Mastitis
Interventions
PROCEDURE

steroid injecting

Group L: Triamcinolone acetonide was administered to the patients through injecting inside the lesion.Group S: Oral methylprednisolone was administered to the patients.

Trial Locations (1)

34255

emine Yildirim, Gaziosmanpaşa

All Listed Sponsors
lead

Gaziosmanpasa Research and Education Hospital

OTHER_GOV

NCT04596046 - Could Intralesional Steroid be the Novel Treatment for Granulomatous Mastitis? | Biotech Hunter | Biotech Hunter